Revelation Partners, a secondary investor in healthcare, closed its newest fund, Revelation Healthcare Fund III, at its hard cap of $350 million. The oversubscribed offering surpassed the initial target of $300 million. The firm invests broadly across all healthcare sub-sectors, including medical devices, diagnostics, biotech, healthcare technology and healthcare services.
“With the tremendous amount of private capital that has flowed into the healthcare space over the last several years, our limited partners continue to see the attractive opportunity for Revelation Partners to provide liquidity in this illiquid market,” said Scott Halsted, founder and managing partner at Revelation Partners.
In addition to the closing of the fund, the firm also announced three recent appointments: Fred Lee, promoted to managing director; Doug Fisher, appointed to venture partner; Suchira Sharma, appointed to Associate.
“We are thrilled to announce the promotion of Fred Lee and the addition of Doug and Suchira to the team,” added Halsted. “With an expanded team, we will be able to accelerate our unique investing model as a source of liquidity to the healthcare ecosystem.”